Progestogens in estrogen-replacement therapy.
Gambrell
R D
RD
Department of Physiology and Endocrinology, Medical College of Georgia, Augusta 30912, USA.
D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004714:Endometrial Hyperplasia / Q000453:epidemiology / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000592:standards*; D005260:Female; D006801:Humans; D015994:Incidence; D050356:Lipid Metabolism; D011372:Progestins / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D011372:Progestins